top of page

BioSurfaces has developed and tested various medical devices for implantable (permanent) and non-implantable (temporary) applications with our technology.  

















Many of these technologies were developed from grants and contracts from the National Institutes of Health and National Science Foundation.  Several of these technologies have completed initial preclinical trials (identified with an asterisk(*)).  These devices have substantial benefits over current commercially available technologies, with their flexibility, drug and bioactive loading capabilities, and improved healing as a result of the nanofibrous structure as compared to other highly porous biomaterials such as expanded ePTFE and woven/knitted textiles.


Click on       below within images to show specific devices

Temporary Devices


  • *Wound Pack/Bandage (Battle Wounds/Accident Victims)

  • Indwelling Catheter Coatings (Cancer/Urinary)


  • HIV Filters (Filtration and Personal Protection Devices)


  • Dermal Regeneration Scaffold (Burns and Diabetic Ulcers)


  • Infection-Resistant Bone Fixation Pins (Orthopedic)

Permanent Devices


  • *NuSpun™ Vascular Graft - Self-Sealing Artificial Access Graft (Kidney Disease)

  • *Small-Diameter Artificial Artery (Peripheral Artery Disease)

  • *Artificial Heart Assist Device Conduit (Heart Disease)


  • Drug-Eluting Stent Jacket (Heart/Vascular Disease)


  • *Drug-Eluting Sutures (Vascular Disease/General Surgery)

•  First synthetic, off-the-shelf, acellular graft with          early access

•  Uses science of extracellular scaffold to promote      tissue integration, which may improve clinical           outcomes

•  Scalable, rapid, automated manufacturing 


•  Conducted extensive benchtop testing, initial

    biocompatibility studies and extended preclinical


•  Superior economics - faster to dialysis, less


Bio-Spun™ Fistula Plug 

Acellular Treatment for Fistulas

  • First non-degradable, off-the-shelf, acellular perianal fistula plug

  • Potential delivery vehicle for stem cells and/or targeted drugs

  • Promotes tissue integration resulting in device anchoring and reduction of fibrosis, which may improve clinical outcomes

  • Simple ease of use and minimally invasive procedure for tract insertion

  • May result in faster recovery with fewer complications

Fistula Plug.jpg
bottom of page